Human papillomavirus-related malignant neoplasm Clinical Trials
Conditions / Human papillomavirus-related malignant neoplasm
Delta Trials tracks 6 clinical trials for Human papillomavirus-related malignant neoplasm in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 0 trials have reached completion. This research is carried out at 13 clinical sites around the world. An additional 6 trials have active registrations outside the recruiting and completed categories. Since 2020, 2 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
6
Total Trials
0
Recruiting
0
Completed
6
Other Active
2
Terminated since 2020
13
Study Locations
Browse by location (13 total)
- Wuhan, China 2 trialsAll trials in Wuhan, China
- Liberia, Costa Rica 1 trialAll trials in Liberia, Costa Rica
- Charlottesville, United States 1 trialAll trials in Charlottesville, United States
- Pittsburgh, United States 1 trialAll trials in Pittsburgh, United States
- Guangzhou, China 1 trialAll trials in Guangzhou, China
- Portland, United States 1 trialAll trials in Portland, United States
- New York, United States 1 trialAll trials in New York, United States
- Seattle, United States 1 trialAll trials in Seattle, United States
- Fairfax, United States 1 trialAll trials in Fairfax, United States
- Duarte, United States 1 trialAll trials in Duarte, United States
- Lexington, United States 1 trialAll trials in Lexington, United States
- Columbus, United States 1 trialAll trials in Columbus, United States
- Morgantown, United States 1 trialAll trials in Morgantown, United States